Bed Bath & Beyond (NASDAQ: BBBY) reported Q2 EPS of $0.34, $0.07 better than the analyst estimate of $0.27. Revenue for the quarter came in at $2.7 billion versus the consensus estimate of $2.75 billion.

• Comparable sales in the fiscal 2019 second quarter declined approximately 6.7%.

GUIDANCE:

Bed Bath & Beyond sees FY2019 EPS of $2.08-$2.13, versus the consensus of $1.86. Bed Bath & Beyond sees FY2019 revenue of $11.4 billion, versus the consensus of $11.36 billion.

• Fiscal 2019 full-year results continue to be in line with the Company's most recent guidance and assumes current investment plans to drive top-line performance in the back half, as well as its comp sales trends year to date, and excludes goodwill and other impairments, severance costs, shareholder activity costs, the inventory write down, and any incremental impact from tariffs. Fiscal 2019 full-year net sales are estimated to be around $11.4 billion and net earnings per diluted share are estimated to be between $2.08 and $2.13.

For earnings history and earnings-related data on Bed Bath & Beyond (BBBY) click here.